# Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US

> **NCT05129345** · — · RECRUITING · sponsor: **Duke University** · enrollment: 150 (estimated)

## Conditions studied

- Hypertension
- Dyslipidemias
- Type 2 Diabetes
- HIV-1-infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05129345
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-07
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05129345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05129345, "Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05129345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*